- Home
- PRLD vs TGE Comparison
PRLD vs TGE Comparison
Compare PRLD & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | TGE |
|---|---|---|
| Founded | 2016 | 2023 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 66.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | TGE |
|---|---|---|
| Price | $1.99 | $1.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 547.0K | 107.8K |
| Earning Date | 03-09-2026 | 10-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | $10,500,000.00 | ★ $130,212,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.17 |
| Revenue Growth | 250.00 | ★ 316.50 |
| 52 Week Low | $0.61 | $0.78 |
| 52 Week High | $4.22 | $37.02 |
Technical Indicators
Market Signals| Indicator | PRLD | TGE |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 60.95 |
| Support Level | $1.90 | $1.30 |
| Resistance Level | $2.20 | $1.69 |
| Average True Range (ATR) | 0.25 | 0.13 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 18.37 | 75.73 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.